Publication | Open Access
386MO Trastuzumab duocarmazine versus physician's choice therapy in pre-treated HER2-positive metastatic breast cancer: Final results of the phase III TULIP trial
17
Citations
1
References
2023
Year
Breast OncologyOncologyChoice TherapyPharmacologyClinical TrialsBreast CancerPharmacotherapyCancer TreatmentMedicineFinal Results
| Year | Citations | |
|---|---|---|
Page 1
Page 1